Table 1 Subject characteristics*
| Â | LTFC N = 125 | LTuFC N = 124 |
|---|---|---|
Female, n (%) | 66 (52.8) | 50 (40.3) |
Age, years, mean (range) | 50.0 (18-75) | 47.9 (17-74) |
Primary open-angle glaucoma, n (%) | 87 (69.6) | 85 (68.5) |
   Duration since diagnosis, years, mean (range) | 4.2 (0.1-30) | 3.1 (0.1-33) |
Ocular hypertension, n (%) | 38 (30.4) | 39 (31.5) |
   Duration since diagnosis, years, mean (range) | 2.7 (0.2-25) | 2.3 (0.2-10) |
Baseline IOP, mmHg, mean ± SD†| 25.8 ± 3.2 | 26.0 ± 3.5 |
Prior medications in ≥10% of subjects, n (%) |  |  |
   Brinzolamide | 101 (80.8) | 93 (75.0) |
   Carteolol hydrochloride | 49 (39.2) | 42 (33.9) |
   Timolol maleate | 28 (22.4) | 33 (26.6) |
   Timolol | 22 (17.6) | 24 (19.4) |
   Carteolol | 15 (12.0) | 13 (10.5) |